| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Calcium/calmodulin-dependent protein kinase type 1 |
|---|
| Ligand | BDBM50425008 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_954053 (CHEMBL2350821) |
|---|
| IC50 | >5000±n/a nM |
|---|
| Citation |  Shao, H; Shi, S; Huang, S; Hole, AJ; Abbas, AY; Baumli, S; Liu, X; Lam, F; Foley, DW; Fischer, PM; Noble, M; Endicott, JA; Pepper, C; Wang, S Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activities. J Med Chem56:640-59 (2013) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Calcium/calmodulin-dependent protein kinase type 1 |
|---|
| Name: | Calcium/calmodulin-dependent protein kinase type 1 |
|---|
| Synonyms: | CAMK1 | CaM kinase I | CaM kinase I alpha | CaM-KI | CaMKI-alpha | Calcium/calmodulin-dependent protein kinase type 1 | KCC1A_HUMAN |
|---|
| Type: | PROTEIN |
|---|
| Mol. Mass.: | 41325.04 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | ChEMBL_655701 |
|---|
| Residue: | 370 |
|---|
| Sequence: | MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE
GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR
LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG
TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP
YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAK
SKWKQAFNATAVVRHMRKLQLGTSQEGQGQTASHGELLTPVAGGPAAGCCCRDCCVEPGT
ELSPTLPHQL
|
|
|
|---|
| BDBM50425008 |
|---|
| n/a |
|---|
| Name | BDBM50425008 |
|---|
| Synonyms: | CHEMBL2312185 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H24N8S |
|---|
| Mol. Mass. | 420.534 |
|---|
| SMILES | CNc1nc(C)c(s1)-c1nc(Nc2cccc(c2)N2CCCNCC2)ncc1C#N |
|---|
| Structure | 
|
|---|
Search and Browse
